Comparison of crystalline and amorphous asparaginase in treatment of acute leukemia in children.
D000293:Adolescent; D000328:Adult; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D001702:Biopharmaceutics; D001780:Blood Coagulation Tests; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007275:Injections, Intravenous; D007677:Kidney Function Tests; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008111:Liver Function Tests; D013997:Time Factors
D001786:Blood Glucose; D001215:Asparaginase